Surrozen, Inc/de Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
SRZN
Surrozen, Inc/deTCG Crossover GP II, LLC and 4 others reported changes in beneficial ownership of Surrozen, Inc./DE common stock on July 22, 2026.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. Chief Financial Officer Andrew Pedrum Maleki acquired 607 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deExecutive Vice President of Research Li Yang acquired 1,666 shares of Surrozen, Inc. common stock via the employee stock purchase plan.
NASDAQ
SRZN
Surrozen, Inc/deChief Operating Officer Charles Williams acquired 1,666 shares of Surrozen, Inc. common stock through the company's Employee Stock Purchase Plan.
NASDAQ
SRZN
Surrozen, Inc/deTim Kutzkey, a Director and 10% Owner of Surrozen, Inc., reported the acquisition of stock options.
NASDAQ
SRZN
Surrozen, Inc/deMace Rothenberg, a Director at Surrozen, Inc., acquired 5,550 stock options with an exercise price of $30.14 on May 13, 2026.
NASDAQ
SRZN
Surrozen, Inc/deDavid J. Woodhouse, a Director at Surrozen, Inc., acquired 5,550 stock options on May 13, 2026, with an exercise price of $30.14.
NASDAQ
SRZN
Surrozen, Inc/deMary Haak-Frendscho, a director at Surrozen, Inc., acquired 5,550 stock options on May 13, 2026.
NASDAQ
SRZN
Surrozen, Inc/deChristopher Y. Chai, a director at Surrozen, Inc., acquired 5,550 stock options.
NASDAQ
SRZN
Surrozen, Inc/deEric Bjerkholt, a Director at Surrozen, Inc., acquired 5,550 stock options with an exercise price of $30.14.
NASDAQ
SRZN
Surrozen, Inc/deAnna Berkenblit, a Director at Surrozen, Inc., acquired 5,550 stock options with an exercise price of $30.14.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. executive Li Yang reported transactions involving common stock and restricted stock units.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. COO Charles O. Williams reported transactions involving the sale of company stock to cover tax obligations related to vested Restricted Stock Units (RSUs).
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. CEO Craig C. Parker reported transactions involving the acquisition of restricted stock units and the subsequent sale of shares to cover tax obligations.
NASDAQ
SRZN
Surrozen, Inc/deForm 4: Surrozen EVP Donates Shares
Surrozen, Inc.'s Executive Vice President of Research, Li Yang, reported a charitable donation of 1,666 shares of common stock.
NASDAQ
SRZN
Surrozen, Inc/deTCG Crossover entities, a 10% owner and director of Surrozen, Inc., acquired 121,881 shares of common stock over two days in March 2026.
NASDAQ
SRZN
Surrozen, Inc/deTCG Crossover entities, a 10% owner and director of Surrozen, Inc., acquired nearly 49,000 shares of common stock in open market purchases totaling approximately $1.2 million.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s Executive Vice President of Research, Yang Li, was granted 100,950 employee stock options and 100,950 restricted stock units, aligning executive incentives with long-term company performance.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s Chief Operating Officer, Charles O. Williams, was granted 102,900 employee stock options and 102,900 restricted stock units.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc. CEO Craig C. Parker was granted 242,200 employee stock options and 242,200 restricted stock units, vesting over four years.
NASDAQ
SRZN
Surrozen, Inc/deForm 4: Insider Buys Surrozen Shares
TCG Crossover funds, a 10% owner and director, increased their stake in Surrozen, Inc. through multiple common stock purchases.
NASDAQ
SRZN
Surrozen, Inc/deTCG Crossover entities, a 10% owner and director, increased their beneficial ownership in Surrozen, Inc. through multiple open market purchases.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen, Inc.'s Chief Operating Officer, Charles O. Williams, was granted 500 employee stock options with an exercise price of $19.595.
NASDAQ
SRZN
Surrozen, Inc/deThe Column Group III GP, LP and affiliated entities acquired over 32,500 shares of Surrozen, Inc. common stock across multiple transactions in mid-January 2026.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen Director Tim Kutzkey, through affiliated entities, acquired additional common stock in January 2026, increasing indirect beneficial ownership.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen Director and 10% owner Tim Kutzkey, through affiliated investment funds, acquired additional common stock in the company on January 13 and 14, 2026.
NASDAQ
SRZN
Surrozen, Inc/deThe Column Group III GP, LP and affiliated entities reported acquiring additional common stock in Surrozen, Inc. through pre-planned transactions.
NASDAQ
SRZN
Surrozen, Inc/deThe Column Group, a significant shareholder and director, increased its indirect beneficial ownership in Surrozen, Inc. by acquiring 15,100 shares of common stock.
NASDAQ
SRZN
Surrozen, Inc/deFunds associated with Surrozen Director Tim Kutzkey acquired additional common stock in the company, increasing their indirect beneficial ownership.
NASDAQ
SRZN
Surrozen, Inc/deSurrozen's Executive Vice President of Research, Yang Li, reported the acquisition of common stock through RSU vesting and subsequent sale of shares to cover tax obligations.